| 2933.59.21 | 00 | Antihistamines, including those principally used as anti-nauseants | kg | 6.5% | Free (A+,AU,BH, CA,CL,D,E,IL,J, JO,K,MA,MX, P,SG) | 15.4￠/kg + 82% |
| 2933.69.60 | 30 | Products used principally for rubber processing | kg | | | |
| 2933.99.55 | | Drugs primarily affecting the central nervous system: | | | | |
| 2933.99.82 | 20 | Tolyltriazole (CAS No. 29385-43-1) | kg | | | |
| 2934 | | Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds: | | | | |
| 2934.99.07 | 00 | Ethyl 2-[4-[(6-chloro-2-benzoxazolyl)oxy]- phenoxy]propanoate (Fenoxaprop-ethyl) | kg | Free | | 15.4￠/kg + 48.5% |
| 2936 | | Provitamins and vitamins, natural or reproduced by synthesis (including natural concentrates), derivatives thereof used primarily as vitamins, and intermixtures of the foregoing, whether or not in any solvent: | | | | |
| 2937 | | Hormones, prostaglandins, thromboxanes and leukotrienes, natural or reproduced by synthesis; derivatives and structural analogues thereof, including chain modified polypeptides, used primarily as hormones: | | | | |
| 2937.11.00 | 00 | Polypeptide hormones, protein hormones and glycoprotein hormones, their derivatives and structural analogues: | | | | |
| 2937.23.10 | | Obtained directly or indirectly from animal or vegetable materials | | Free | | 25% |
| 2938 | | XII. GLYCOSIDES AND VEGETABLE ALKALOIDS, NATURAL OR REPRODUCED BY SYNTHESIS, AND THEIR SALTS, ETHERS, ESTERS AND OTHER DERIVATIVES | | | | |
| 2938 | | Glycosides, natural or reproduced by synthesis, and their salts, ethers, esters and other derivatives: | | | | |
| 2939.63.00 | 00 | Lysergic acid and its salts | kg | Free | | 25% |
| 2940..00 | | Sugars, chemically pure, other than sucrose, lactose, maltose, glucose and fructose; sugar ethers, sugar acetals and sugar esters, and their salts, other than products of heading 2937, 2938 or 2939: | | | | |
| 2941.90.10 | 10 | Aminoglycoside antibiotics | kg | | | |
| 3004.40.00 | 60 | Medicaments primarily affecting the eyes, ears or respiratory system | kg | | | |
| 3004.40.00 | 20 | Medicaments primarily affecting the central nervous system: | | | | |
| 3004.50.10 | 00 | Containing vitamins synthesized wholly or in part from aromatic or modified aromatic industrial organic compounds: | | | | |
| 3004.90.91 | 65 | Preparations primarily affecting the electrolytic, caloric or water balance: | | | | |
| 3004.90.91 | 22 | Medicaments primarily affecting the central nervous system: | | | | |
| 3004.90.91 | 50 | Medicaments primarily affecting the digestive system: | | | | |
| 3101.00.00 | 00 | Animal or vegetable fertilizers, whether or not mixed together or chemically treated; fertilizers produced by the mixing or chemical treatment of animal or vegetable products | t | Free | | Free |
| 3201.90.25 | 00 | Extracts of canaigre, chestnut, curupay, divi-divi, eucalyptus, gambier, hemlock, larch, mangrove, myrobalan, oak, sumac, tara, urunday or valonia | kg | Free | | Free |
| 3202.90.10 | 00 | Consisting wholly of inorganic subtances | kg | Free | | 25% |
| 3203.00 | | Coloring matter of vegetable or animal origin (including dyeing extracts but excluding animal black), whether or not chemically defined; preparations as specified in note 3 to this chapter based on coloring matter of vegetable or animal origin: | | | | |
